Seno’s management team has extensive experience in the commercialization of medical device products. The team has been selected based upon their experience in development and expertise to understand the regulatory hurdles involved in commercializing such products.

Mr. Umbel is Chief Executive Officer of Seno Medical Instruments, Inc. Tom Umbel brings more than 30 years of medical device and diagnostics leadership experience to Seno Medical. He has lead several start-up companies, including one through a successful acquisition. He has also managed large organizations through significant growth leading both the strategic development and M&A efforts in his previous roles.

Tom was most recently the VP of Business Development for Bioventus, a privately held ortho-biologics company in Durham, NC. Tom has led the Business Development efforts at both Bioventus and Hologic, the largest dedicated Women’s Health company in the U.S. Tom’s role in managing mergers and acquisitions helped to grow Hologic from a small single-product company with $100 million in revenue to a large diversified company with more than $2.5 billion in sales in his 15 years with the company.

Prior to Hologic, Tom was the President of Direct Radiography Corp. (DRC). He led the development and commercialization of the digital x-ray detector technology, which he ultimately sold to Hologic in 1999. This company’s technology became the core to Hologic’s market leading digital mammography system and was the engine to Hologic’s significant growth.

Prior to DRC, Tom worked at Sterling Diagnostic Imaging for 3 years and DuPont for 20 years. At those two companies, Tom held senior management positions in operations, engineering, sales and marketing.

Tom has a BS in Chemical Engineering from Grove City College.

Mr. Davis is Chief Financial Officer of Seno Medical Instruments, Inc. Eric brings more than 26 years of financial and operational leadership with extensive domestic and international experience. He’s co-led several M&A efforts resulting in aggregate purchase prices over $500M and secured over $200M in investment capital. He’s a critical strategic thinker who also has the ability to define and implement at a tactical level.

Eric was most recently the Chief Financial Officer of CeloNova BioSciences, Inc., a privately held medical device company who sold their Interventional Radiology/Oncology business to Boston Scientific at the end of 2015. Prior to CeloNova, Eric was the Chief Financial and Operating Officer at Genesis Networks Enterprises, LLC where he led the finance and accounting operations of a $1 billion network integrations and supply chain management company.

Prior to Genesis, Eric spent time operating as senior finance and operations management in the Oil and Gas, Banking and Brokerage and Aero-Defense industries.

Eric holds an MBA from Baylor University and BSBA in Management from the University of Tulsa. He’s also been inducted into the prestigious Beta Gamma Sigma honor society as a lifetime member and awarded Chartered Fellow (CMgr FCMI) by the Chartered Management Institute and Fellow Chartered Management Accountant (FCMA) and Chartered Global Management Accountant (CGMA) by the Chartered Institute of Management Accountants. He also holds certifications from Villanova University as a Certified Six Sigma Black Belt (CSSBB) and Certified Lean Six Sigma Sensei (CLSSS).

Dr. Stavros joined the company as Chief Medical Officer in mid-2012. Dr. Stavros is a women‘s imaging radiologist with more than 30 years of breast imaging experience.  Dr. Stavros has been involved in mammography since 1976 and has been actively involved in the development of high-frequency hand-held breast ultrasound since 1981. Dr. Stavros’s main interests are general ultrasound, breast imaging and intervention, and ultrasound guided FNA and/or core biopsy in the thyroid and head and neck.

Dr. Stavros is a reviewer for several medical journals. He has written or co-authored numerous articles including the definitive textbook for reference and learning in the specialty, Breast Ultrasound. Dr. Stavros is recognized as a leader in the field of breast ultrasound and speaks globally on this topic having presented more than 2,000 invited lectures and abstracts.

Dr. Stavros is a fellow of the American College of Radiology, a fellow of the Society of Radiologists in Ultrasound, an honorary fellow of the Royal Australian and New Zealand College of Radiology, where he was the Traveling Baker Professor in 1999, and is Professor Specialist at the University of Texas Health Science Center at San Antonio. He has served on numerous panels and companies as a medical advisor and is an investor in many companies.

Tammy Garcia joined the company as SVP, Sales and Marketing late summer of 2016. She previously served as the General Manager, Breast Imaging for GE Healthcare. Tammy brings over 25 years of commercial sales and marketing leadership experience in medical device and diagnostic imaging with a significant part of her career and passion focused on women’s health and improving cancer detection.

During her 13-year tenure at GE Healthcare, Tammy held several leadership roles where she established commercial teams focused on double digit growth in Orthopedics and Breast Imaging.  Additionally, Tammy led the sales and marketing efforts in the launches of disruptive technologies with InSightec, an MRI guided focused ultrasound non-invasive surgical therapy, and MAKO Surgical, an orthopedic robotic device and implant company. Early in her career, she held sales and service leadership roles at Sterling Diagnostic Imaging and DuPont.

Tammy has an MBA from University of Phoenix, Phoenix, AZ and BS in Management from Cardinal Stritch University in Wisconsin. She currently is the President of the Board of Susan G. Komen Wisconsin Affiliate.

Steve Miller,  Senior Vice President, Engineering has dedicated the majority of his career in the development of innovative medical imaging products, starting 30 years ago with research in Ultrasound and Nuclear Magnetic Resonance as a graduate student at Stanford University. He has led international engineering teams in the development of innovative and high performance ultrasound imaging systems and transducers at Philips, GE, and FUJIFILM SonoSite. His focus on innovation to address customer needs has resulted in products at GE and SonoSite that are the globally top-selling products in their categories.

Steve was most recently the Vice President of Product Realization at FUJIFILM SonoSite with headquarters in Bothell, Washington. Steve was responsible for taking innovative new concepts to volume production, including engineering, manufacturing, supply chain, and product management. FUJFILM SonoSite is the global leader in ultrasound products designed specifically for point-of-care markets.

Prior to SonoSite, Steve held various leadership engineering roles at GE Healthcare. His most recent role was Engineering General Manager for GE Healthcare’s Global Ultrasound Probe division managing engineering teams in seven countries. In this position, he initiated and led the development of a new generation of transducers subsequently branded by GE as XDClear.

Steve is committed to innovations developed with diverse collaborative teams that impact patients and customers. He is personally an inventor on more than 30 patents, while leading teams that have been awarded more than 200 patents.

Curious about opto-acoustics?

Review some of our frequently asked questions on our FAQ page.

Recently, Dr. Mike Linver, on behalf of his colleagues at the 24th Annual Mammography meeting in Santa Fe, recognized Dr. Stavros for his 40+ years of contribution to breast imaging. Dr. Stavros’ humility and brilliance in ultrasound and breast imaging have had lasting impact on radiologists and sonographers globally. Congratulations, Dr. Stavros!